To clarify whether treatment of the CML patients with HU, IFNα or TKI was associated with activation of latent and/or persistent virus infections, we tested sera from the patients for presence of antibodies against four human herpesviruses and six human papillomaviruses. Here, IFNA17 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.